Therapeutic Area | MeSH |
---|---|
nutritional and metabolic diseases | D009750 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
KAYEXALATE | Concordia Laboratories | N-011287 DISCN | 1982-01-01 | 1 products, RLD |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
hyperkalemia | HP_0002153 | D006947 | E87.5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hyperkalemia | D006947 | HP_0002153 | E87.5 | — | 1 | — | 3 | 1 | 5 |
Insulin resistance | D007333 | HP_0000855 | E88.819 | — | — | — | 1 | 1 | 2 |
Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | — | — | — | 1 | — | 1 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | — | — | 1 | — | 1 |
Heart rate | D006339 | EFO_0004326 | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Parkinson disease | D010300 | EFO_0002508 | G20 | — | — | 2 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 4 | 1 | — | — | — | 4 |
Rett syndrome | D015518 | Orphanet_778 | F84.2 | — | 1 | — | — | — | 1 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 1 | — | — | — | 1 |
Heart failure | D006333 | HP_0001635 | I50 | — | 1 | — | — | — | 1 |
Diabetic foot | D017719 | EFO_1001459 | — | — | 1 | — | — | — | 1 |
Pseudohypoaldosteronism | D011546 | — | — | — | 1 | — | — | — | 1 |
Autosomal dominant polycystic kidney | D016891 | EFO_1001496 | Q61.2 | — | 1 | — | — | — | 1 |
Hyperphosphatemia | D054559 | HP_0002905 | — | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pharmacokinetics | D010599 | — | — | 2 | — | — | — | — | 2 |
Autoimmune diseases | D001327 | HP_0002960 | M30-M36 | 2 | — | — | — | — | 2 |
Cough | D003371 | HP_0012735 | R05 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Acute kidney injury | D058186 | HP_0001919 | N17 | — | — | — | — | 2 | 2 |
Chronic renal insufficiency | D051436 | — | N18 | — | — | — | — | 1 | 1 |
Rotator cuff injuries | D000070636 | — | M75.1 | — | — | — | — | 1 | 1 |
Rehabilitation | D012046 | — | — | — | — | — | — | 1 | 1 |
Spinal cord injuries | D013119 | EFO_1001919 | — | — | — | — | — | 1 | 1 |
Pediatric obesity | D063766 | — | — | — | — | — | — | 1 | 1 |
Shoulder impingement syndrome | D019534 | EFO_1001178 | M75.4 | — | — | — | — | 1 | 1 |
Drug common name | Sodium polystyrene sulfonate |
INN | — |
Description | Polystyrene sulfonates are a group of medications used to treat high blood potassium. Effects generally take hours to days. They are also used to remove potassium, calcium, and sodium from solutions in technical applications.
|
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | 123333-94-8 |
RxCUI | — |
ChEMBL ID | CHEMBL1201484 |
ChEBI ID | — |
PubChem CID | 75905 |
DrugBank | DB01344 |
UNII ID | — |